These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29422597)

  • 1. From genetics to the clinic: a translational perspective on follicular lymphoma.
    Huet S; Sujobert P; Salles G
    Nat Rev Cancer; 2018 Apr; 18(4):224-239. PubMed ID: 29422597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin modifying gene mutations in follicular lymphoma.
    Green MR
    Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
    van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
    Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
    Kumar E; Pickard L; Okosun J
    Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to treat patients with relapsed follicular lymphoma.
    Cheah CY; Seymour JF
    Expert Rev Hematol; 2017 Mar; 10(3):187-191. PubMed ID: 28164722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular Lymphoma: Past, Present, and Future.
    Becnel MR; Nastoupil LJ
    Curr Treat Options Oncol; 2018 May; 19(7):32. PubMed ID: 29796824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
    Araujo-Ayala F; Pérez-Galán P; Campo E
    Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature and importance of follicular lymphoma precursors.
    Mamessier E; Broussais-Guillaumot F; Chetaille B; Bouabdallah R; Xerri L; Jaffe ES; Nadel B
    Haematologica; 2014 May; 99(5):802-10. PubMed ID: 24790058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The routes for transformation of follicular lymphoma.
    Okosun J; Montoto S; Fitzgibbon J
    Curr Opin Hematol; 2016 Jul; 23(4):385-91. PubMed ID: 27135979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
    Green MR; Gentles AJ; Nair RV; Irish JM; Kihira S; Liu CL; Kela I; Hopmans ES; Myklebust JH; Ji H; Plevritis SK; Levy R; Alizadeh AA
    Blood; 2013 Feb; 121(9):1604-11. PubMed ID: 23297126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology, pathogenesis and molecular genetics of follicular NHL.
    Leich E; Ott G; Rosenwald A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of follicular lymphoma transformation.
    Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
    Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future therapeutic approaches for the treatment of follicular lymphoma.
    Pulsoni A; Cappelli LV; Ballotta L; Canichella M; Serrao A; Annechini G; D'Elia GM; Foà R
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):931-941. PubMed ID: 29972084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
    Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
    PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressors in follicular lymphoma.
    Graham C; LeBrun DP
    Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.